Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Franziska Niehr

CCI-779 (Temsirolimus) Exhibits Increased Anti-Tumor Activity in Low EGFR Expressing HNSCC Cell Lines and Is Effective in Cells With Acquired Resistance to Cisplatin or Cetuximab

Journal of Translational Medicine

English

Spheroid Culture of Head and Neck Cancer Cells Reveals an Important Role of EGFR Signalling in Anchorage Independent Survival

PLoS ONE

Multidisciplinary

2016

English

Related publications

Nuclear EGFR Contributes to Acquired Resistance to Cetuximab

English

P1.13-13 Potent Anti-Tumor Effect of Ganetespib in Acquired EGFR-TKI Resistance NSCLC Cells

Journal of Thoracic Oncology

English

Lymphotoxin-Β Interacts With Methylated EGFR to Mediate Acquired Resistance to Cetuximab in Head and Neck Cancer

Clinical Cancer Research

Cancer Research

Oncology

2017

English

Dual Kinase Inhibition of EGFR and HER2 Overcomes Resistance to Cetuximab in a Novel in Vivo Model of Acquired Cetuximab Resistance

Clinical Cancer Research

Cancer Research

Oncology

2011

English

Aberrant HER3 Ligand Heregulin-Expressing Head and Neck Squamous Cell Carcinoma Is Resistant to Anti-Egfr Antibody Cetuximab, but Not Second-Generation EGFR-TKI

English

Over-Expression of BAG-1 in Head and Neck Squamous Cell Carcinomas (HNSCC) Is Associated With Cisplatin-Resistance

Journal of Translational Medicine

English

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

Molecular Cancer Research

English

Emergence of KRAS Mutations and Acquired Resistance to Anti-Egfr Therapy in Colorectal Cancer

Nature

Multidisciplinary

2012

English

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-Egfr Therapy and Molecularly Selected by Circulating Tumor DNA Analyses

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Franziska Niehr

CCI-779 (Temsirolimus) Exhibits Increased Anti-Tumor Activity in Low EGFR Expressing HNSCC Cell Lines and Is Effective in Cells With Acquired Resistance to Cisplatin or Cetuximab

Spheroid Culture of Head and Neck Cancer Cells Reveals an Important Role of EGFR Signalling in Anchorage Independent Survival

Related publications

Nuclear EGFR Contributes to Acquired Resistance to Cetuximab

P1.13-13 Potent Anti-Tumor Effect of Ganetespib in Acquired EGFR-TKI Resistance NSCLC Cells

Lymphotoxin-Β Interacts With Methylated EGFR to Mediate Acquired Resistance to Cetuximab in Head and Neck Cancer

Dual Kinase Inhibition of EGFR and HER2 Overcomes Resistance to Cetuximab in a Novel in Vivo Model of Acquired Cetuximab Resistance

Aberrant HER3 Ligand Heregulin-Expressing Head and Neck Squamous Cell Carcinoma Is Resistant to Anti-Egfr Antibody Cetuximab, but Not Second-Generation EGFR-TKI

Over-Expression of BAG-1 in Head and Neck Squamous Cell Carcinomas (HNSCC) Is Associated With Cisplatin-Resistance

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

Emergence of KRAS Mutations and Acquired Resistance to Anti-Egfr Therapy in Colorectal Cancer

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-Egfr Therapy and Molecularly Selected by Circulating Tumor DNA Analyses